hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

New UN report sees opportunities for better access to medicines in poor countries via investment in responsible local production

Get RSS feed of these results

All components of this story

Article
9 May 2011

UNCTAD: Bundle Of Opportunities To Improve Medicines Access In LDCs

Author: Catherine Saez, Intellectual Property Watch [Switzerland]

Access to essential medicines in least developed countries (LDCs) could be facilitated through local production, according to a report released today by the United Nations Conference on Trade and Development...[M]ajor players in developed countries[are] facing the expiration of patents on some high-revenue drugs, and a shortage of new drugs to replace them...pushing those companies to seek partnerships with prominent generic manufacturers both in developed and in developing countries...[S]ome caution needs to be exercised, the report said...“[I]nvestors will need assurances by governments” that the basic prerequisites for the manufacture of high-quality medicines at low cost are present in the countries...The choice of medicines to be produced locally... needs to follow a public health perspective...technology transfer needs to be part of any investment in the local production or pharmaceuticals...

Read the full post here

Article
9 May 2011

[PDF] Investment in Pharmaceutical Production in the Least Developed Countries: A Guide for Policy Makers and Investment Promotion Agencies

Author: UN Conference on Trade and Development

This guide outlines...recent trends, the basic prerequisites for the local production of pharmaceuticals and the key points that policymakers and investment negotiators especially from investment promotion agencies, will need to keep in mind in efforts to support this important sector...

Read the full post here